Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Charles River Laboratories International Inc CRL

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its... see more

Recent & Breaking News (NYSE:CRL)

Farmland Partners Inc. Acquires 8,349 Acres of Louisiana Farmland for $26.8 Million

PR Newswire June 1, 2021

Taylor Morrison Extends and Increases Stock Repurchase Program

PR Newswire June 1, 2021

Firm Capital Property Trust Announces $25 Million Bought Deal Financing of Trust Units

Canada NewsWire May 31, 2021

Killam Apartment REIT Closes $109.3 Million Public Offering of Trust Units

Canada NewsWire May 31, 2021

WSGF Previews Short-Term Vacation Rental Property Backed Cryptocurrency

PR Newswire May 28, 2021

Charles River Laboratories to Participate in June Investor Conferences

Business Wire May 28, 2021

Charles River Laboratories to Host Virtual Investor Day

Business Wire May 26, 2021

Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities

Business Wire May 17, 2021

Charles River Laboratories International Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

PR Newswire May 10, 2021

Charles River Laboratories Announces First-Quarter 2021 Results

Business Wire May 4, 2021

Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call

Business Wire April 13, 2021

Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

Business Wire April 6, 2021

Charles River Laboratories Acquires Retrogenix

Business Wire March 31, 2021

Charles River Laboratories Completes the Acquisition of Cognate BioServices

Business Wire March 29, 2021

Charles River Laboratories Announces Closing of Senior Notes Offering

Business Wire March 23, 2021

Charles River Laboratories Prices $1 Billion of Senior Notes

Business Wire March 9, 2021

Charles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes

Business Wire March 8, 2021

Charles River Laboratories to Present at Barclays Global Healthcare Conference

Business Wire March 8, 2021

Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies

Business Wire February 25, 2021

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance

Business Wire February 17, 2021